Skip to main content
TipRanks
Go Ultimate75% OFF

Yield10 Bioscience (YTENQ) Financial Statements

330 Followers

Yield10 Bioscience Financial Overview

Yield10 Bioscience's market cap is currently $69. The company's EPS TTM is ―; its P/E ratio is ―; Yield10 Bioscience has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue―――――
Gross Profit$ 60.00K$ -7.30M$ 6.82M$ 6.16M$ -4.04M
Operating Income$ -14.42M$ -13.45M$ -11.69M$ -9.61M$ -8.60M
EBITDA$ -14.16M$ -13.15M$ -11.47M$ -9.43M$ -13.01M
Net Income$ -14.46M$ -13.57M$ -11.03M$ -10.21M$ -12.96M
Balance Sheet
Cash & Short-Term Investments―――――
Total Assets$ 3.91M$ 8.09M$ 20.41M$ 14.52M$ 16.72M
Total Debt$ 3.18M$ 2.65M$ 3.17M$ 3.62M$ 4.22M
Net Debt$ 2.11M$ -1.70M$ -12.82M$ -6.08M$ -6.90M
Total Liabilities$ 6.39M$ 3.69M$ 4.39M$ 4.99M$ 5.83M
Stockholders' Equity―――――
Cash Flow
Free Cash Flow$ -10.11M$ -11.56M$ -9.44M$ -8.72M$ -8.71M
Operating Cash Flow―――――
Investing Cash Flow―――――
Financing Cash Flow―――――

Currency in USD

Yield10 Bioscience Earnings and Revenue History

-15M-10M-5M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20182019202020212022RevenueEarningsProfit Margin

Yield10 Bioscience Liabilities to Assets

08M16M24M15 %30 %45 %60 %LiabilitiesLiabilities to Assets20182019202020212022AssetsLiabilitiesLiabilities to Assets

Yield10 Bioscience Cash Flow

00.30.50.811.320182019202020212022OperatingInvestingFinancing

Yield10 Bioscience Forecast EPS vs Actual EPS

-20-15-10-505Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24EPS EstimateBeatMiss